Ocuphire Pharma Inc (OCUP)
1.735
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
1.74
0.00 (0.00%)
After-Hours: 20:00
Ocuphire Pharma Profit Margin (Quarterly): -415.3% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -415.3% |
| December 31, 2023 | -283.6% |
| September 30, 2023 | 46.59% |
| June 30, 2023 | -135.0% |
| March 31, 2023 | -331.1% |
| December 31, 2022 | 85.17% |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -865.0% |
| June 30, 2021 | -7.14K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-7.14K%
Minimum
Jun 2021
85.17%
Maximum
Dec 2022
-1.13K%
Average
-307.3%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -25.09% |
| Return on Assets | -22.71% |
| Return on Invested Capital | -25.09% |
| Operating Margin (Quarterly) | -450.5% |
| Return on Net Operating Assets | -192.0% |